"Ask Me Anything": Ten Answers To Your Questions About ADHD Medication Pregnancy > 자유게시판

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There aren't many studies regarding how exposure over time may affect the pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of using them against the risks to the foetus. Doctors don't have enough data to provide clear recommendations however they can provide information on risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking cheapest adhd medication medication during early pregnancy were not at a greater risk of fetal malformations, or structural birth defects. The researchers used a large population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy and those who had not. Clinical geneticists and pediatric cardiologists looked over the cases to ensure accurate case classification and to minimize the chance of bias.

However, the researchers' study had its limitations. The researchers were unable to, in the first place to distinguish the effects triggered by the medication from the disorder. That limitation makes it difficult to know whether the small differences observed in the groups that were exposed are due to medication use or confounding by comorbidities. The researchers also did not study the long-term effects for the offspring.

The study found that babies whose mothers had taken ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medication was used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated risk of having a caesarean delivery or having a baby with low Apgar score (less than 7). These increases didn't appear to be influenced by the type of medication that was used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefits for both mother and child of continuing treatment for the woman's disorder. Physicians should speak with their patients about this and, if possible, help them improve coping skills which could reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. These decisions are frequently made without clear and authoritative evidence. Instead, doctors must consider their own expertise, the experience of other doctors and the research on the subject.

The issue of risk to infants is extremely difficult. Many studies on this subject are based on observational data instead of controlled research and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these shortcomings, by examining both data on live and deceased births.

The conclusion The conclusion: While some studies have found a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship, and most studies demonstrate a neutral or slight negative effect. Therefore, a careful risk/benefit analysis must be done in each case.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. In addition, a decrease in medication can interfere with the ability to perform work-related tasks and safely drive that are crucial aspects of a normal life Genetic testing for adhd medications many people with ADHD.

She suggests that women who are unsure whether to continue taking medication or stop due to pregnancy should educate family members, coworkers, and their friends about the condition, the impact on daily functioning and the benefits of keeping the current treatment plan. It can also help a woman feel confident about her decision. Certain medications can pass through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug may be transferred to her infant.

Birth Defects and Risk of

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what medication is given for adhd impact the drugs might have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Using two massive data sets, researchers were able to analyze more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.

The researchers behind the study found no association between early medication use and other congenital abnormalities, such as facial clefting or club foot. The results are in agreement with previous studies that have shown an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication before pregnancy. This risk increased during the latter stages of pregnancy, when a lot of women decided to stop taking their medication.

Women who used ADHD medications during the first trimester of their pregnancy were also more likely to have caesarean section, low Apgar score following delivery, and a baby who required help breathing at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have other medical issues that could have contributed to these findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. The researchers recommend that, while discussing benefits and risks are important, the choice regarding whether or not to stop medication should be made based on the severity of each woman's ADHD symptoms and her requirements.

The authors caution that, while stopping the medication is a possibility to consider, it is not recommended because of the high incidence of depression and other mental problems in women who are expecting or have recently given birth. Additionally, the research suggests that women who choose to stop taking their medications are more likely to have difficulties getting used to life without them after the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women who suffer from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments, prepare for the birth of their child and adjust to new routines. As such, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The risk for nursing infant is low because the majority of stimulant medications passes through breast milk at a low level. The rate of medication exposure will vary based on the dosage the medication is administered, its frequency and the time of day. Additionally, different drugs enter the infant's system via the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn is not fully comprehended.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant drugs during a woman's pregnancy. This is a difficult decision for the patient, who must balance the benefits of keeping her medication against the possible dangers to the fetus. In the meantime, until more information is available, doctors can ask pregnant patients if they have a history of ADHD or if they plan to take medication in the perinatal phase.

Many studies have shown that women can a doctor prescribe adhd medication without a diagnosis continue taking their ADHD medication in a safe manner while breastfeeding and during pregnancy. In response, a rising number of patients are opting to do so. They have discovered through consultation with their doctor that the benefits of continuing their current medication outweigh any risk.

Women with ADHD who are planning to nurse should seek advice from an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and build the coping mechanisms. This should be a multidisciplinary approach including obstetricians, GPs, and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, and monitoring for indicators of deterioration, and, if needed adjustments to the medication regime.